1. Organic Ion Transporters and Statin Drug Interactions

   • Kenneth Kellick

   Statin Drugs (Barbara Wiggins, Section Editor) 25 November 2017 Article: 65

   

2. Community Interventions to Increase Stroke Preparedness and Acute Stroke Treatment Rates

   • Kathleen M. Kelly
   • Kathryn T. Holt
   • Lesli E. Skolarus

   Cardiovascular Disease and Stroke (Shyam Prabhakaran, Section Editor) 16 November 2017 Article: 64

   

3. Glycocalyx in Atherosclerosis-Relevant Endothelium Function and as a Therapeutic Target

   • Ronodeep Mitra
   • Gerard Leland O’Neil
   • Eno Essien Ebong

   Vascular Biology (J. Hamilton, Section Editor) Open access 10 November 2017 Article: 63

   

4. ApoCIII as a Cardiovascular Risk Factor and Modulation by the Novel Lipid-Lowering Agent Volanesorsen

   • Natalia A. Rocha
   • Cara East
   • Peter A. McCullough

   Nonstatin Drugs (E. deGoma, Section Editor) 09 November 2017 Article: 62

   

5. Implementing Evidence-Based Practices for Acute Stroke Care in Low- and Middle-Income Countries

   • Rasha Khatib
   • Assef M. Jawaada
   • Mark D. Huffman

   Cardiovascular Disease and Stroke (Shyam Prabhakaran, Section Editor) 08 November 2017 Article: 61

   

6. Review of Cardiometabolic Effects of Prescription Omega-3 Fatty Acids

   • Megan F. Burke
   • Frances M. Burke
   • Daniel E. Soffer

   Nonstatin Drugs (E. deGoma, Section Editor) 07 November 2017 Article: 60

   

7. Early Rehabilitation After Stroke: a Narrative Review

   • Elisheva R. Coleman
   • Rohitha Moudgal
   • Wuwei Feng

   Cardiovascular Disease and Stroke (S. Prabhakaran, Section Editor) 07 November 2017 Article: 59

8. Cardiovascular Risk Factors After Single Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy (SADI-S): a New Effective Therapeutic Approach?

   • Antonio Torres
   • Miguel A. Rubio
   • Andrés Sánchez-Pernaute

   Lipid and Metabolic Effects of Gastrointestinal Surgery (R. Cohen, Section Editor) 07 November 2017 Article: 58

   

9. Atherosclerosis, Periodontal Disease, and Treatment with Resolvins

   • James A. Hamilton
   • Hatice Hasturk
   • Thomas Van Dyke

   Vascular Biology (J. Hamilton, Section Editor) 06 November 2017 Article: 57

   

10. Antiplatelet Therapy for Secondary Prevention of Vascular Disease Complications

    • Rahul R. Goli
    • Mayur M. Contractor
    • Jay Giri

    Nonstatin Drugs (E. deGoma, Section Editor) 04 November 2017 Article: 56

    

11. Novel Approaches for HDL-Directed Therapies

    • Jacques Genest
    • Hong Y. Choi

    Nonstatin Drugs (E. deGoma, Section Editor) 04 November 2017 Article: 55

    

12. The Emergence of “Simpler” Surgical Options to Treat Obesity and Metabolic Syndrome

    • Ricardo Cohen

    Lipid and Metabolic Effects of Gastrointestinal Surgery (R. Cohen, Section Editor) 02 November 2017 Article: 54

13. Emerging Associations Between Neutrophils, Atherosclerosis, and Psoriasis

    • G. E. Sanda
    • A. D. Belur
    • Nehal N. Mehta

    Vascular Biology (J. Hamilton, Section Editor) 30 October 2017 Article: 53

    

14. Improving Regional Stroke Systems of Care

    • Melissa S. Eng
    • Anand V. Patel
    • Jeffrey M. Katz

    Cardiovascular Disease and Stroke (Shyam Prabhakaran, Section Editor) 24 October 2017 Article: 52

    

15. Is Mini-Gastric Bypass a Rational Approach for Type-2 Diabetes?

    • Reem Abou Ghazaleh
    • Matthieu Bruzzi
    • Jean-Marc Chevallier

    Lipid and Metabolic Effects of Gastrointestinal Surgery (R. Cohen, Section Editor) 24 October 2017 Article: 51

16. Delayed Cerebral Ischemia after Subarachnoid Hemorrhage: Beyond Vasospasm and Towards a Multifactorial Pathophysiology

    • Joseph R. Geraghty
    • Fernando D. Testai

    Cardiovascular Disease and Stroke (S. Prabhakaran, Section Editor) 23 October 2017 Article: 50

    

17. PCSK9 Mutations in Familial Hypercholesterolemia: from a Groundbreaking Discovery to Anti-PCSK9 Therapies

    • Petra El Khoury
    • Sandy Elbitar
    • Marianne Abifadel

    Genetics and Genomics (Ali Marian, Section Editor) 17 October 2017 Article: 49

    

18. The Use of Primary Prevention Statin Therapy in Those Predisposed to Atherosclerosis

    • Michael Garshick
    • James A. Underberg

    Statin Drugs (B. Wiggins, Section Editor) 17 October 2017 Article: 48